2Pittet D, Wenzel RP. Nosocomial bloodstream infection. Secular trends in rates, mortality, and contribution to total hospital deaths. [J]. Arch Intern Med,1995, 155:1177
3Turndge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. [J]. Int J Antimicrob Agents, 1999, 12: S23
4Budavari S. The Merck Index. 11th ed. [M]. Rahway, New Jersey: Merck and Company, 1989: 676
5Verbist L. The antimicrobial activity of fusidic acid. [J]. J Antimicrob Chemother, 1990, 25(Suppl B): 1
6Taburet AM, Guibert J, Kitzis MD, et al. Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of new formulation. [J]. J Antimicrob Chemother, 1990, 25(Suppl B): 23
7Tanaka N, Kinoshita T, Masukawa H. Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. [J]. Biochem Biophys Res Commun, 1968, 15: 278
8Cundliffe E. The mode of action of fusidic acid. [J]. Biochem Biophys Res Commun, 1972, 46: 1794
9Yaskowiak ES, March PE. Small clusters of divergent amino acids surrounding the effector domain mediate the varied phenotyoes of EF-G and LepA expression. [J]. Mol Microbiol,1995, 15: 943
10Collignon P, Turndge J. Fusidic acid in vitro activity. [J]. Int J Antimicrobial Agents, 1999, 12: S45
